<- Go Home
Somnus Medical Technology
As of June 11, 2001, Somnus Medical Technologies, Inc. was acquired by Gyrus Group PLC. Somnus Medical Technologies, Inc. engages in the design, development, manufacture, and marketing of medical devices in the United States. Its medical devices utilize proprietary radiofrequency technology for the management and treatment of upper airway disorders. The company offers its Somnoplasty system for minimally-invasive and curative treatment alternatives to the disorders of the upper airway, including habitual snoring, obstructive sleep apnea syndrome, chronic turbinate hypertrophy, and coagulation of tissue in the head and neck, which may include tonsils. It sells its products through sales force and a manufacture representative group to ear, nose and throat physicians, oral maxillofacial surgeons, pulmonologists, sleep medicine specialists, allergists, and other physicians who treat upper airway disorders. Somnus Medical was incorporated in Delaware in 1996 and is headquartered in Sunnyvale, California.
Market Cap
$53.3M
Volume
61.2K
Cash and Equivalents
$2.0M
EBITDA
-$9.4M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
$5.8M
Profit Margin
48.77%
52 Week High
$5.36
52 Week Low
$0.38
Dividend
N/A
Price / Book Value
14.30
Price / Earnings
-4.15
Price / Tangible Book Value
14.30
Enterprise Value
N/A
Enterprise Value / EBITDA
N/A
Operating Income
-$10.4M
Return on Equity
120.97%
Return on Assets
-43.08
Cash and Short Term Investments
$2.0M
Debt
N/A
Equity
$3.7M
Revenue
$11.9M
Unlevered FCF
-$10.7M
Sector
Health Care Equipment and Supplies
Category
N/A
Hedge Funds that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).
Upgrade to Yellowbrick PremiumYellowbrick Portfolios that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).
Upgrade to Yellowbrick Premium